|1.||Koulla-Shiro, Sinata: 1 article (01/2015)|
|2.||Sime, Paule Sandra D: 1 article (01/2015)|
|3.||Bigna, Jean Joel R: 1 article (01/2015)|
|4.||Tillmann, H L: 1 article (05/2001)|
|5.||Kubicka, S: 1 article (05/2001)|
|6.||Grundey, A: 1 article (05/2001)|
|7.||Chen, D F: 1 article (05/2001)|
|8.||Böker, K: 1 article (05/2001)|
|9.||Stangel, W: 1 article (05/2001)|
|10.||Berning-Haag, A: 1 article (05/2001)|
|1.||Kaposi Sarcoma (Kaposi's Sarcoma)
01/01/1991 - "The highest phenotypic frequency for a disease association marker in the study was for HLA-DR5 (62.9%) in the HIV-infected African American population without Kaposi's sarcoma compared to a frequency of 28.9% for the regional control group (p = 0.0012). "
02/15/1987 - "HLA studies of endemic African Kaposi's sarcoma patients and matched controls: no association with HLA-DR5."
11/01/1998 - "Previous reports have described possible associations of familial Kaposi's sarcoma with HLA-DR5 and Paget's disease with DR2. "
06/01/1989 - "Kaposi's sarcoma is associated with an increased frequency of HLA-DR5. "
04/01/1991 - "Recent data indicate that non-AIDS-related Kaposi's sarcoma shows a predilection for individuals with the HLA-DR5 haplotype and that this genetic locus may affect immune function. "
|2.||Sarcoidosis (Schaumann Disease)
01/01/1996 - "To confirm the significant association of sarcoidosis with HLA-DR5, -DR6, and -DR8 associated DRB1 alleles, in sarcoidosis patients from the eastern Japan (Kanto) area found in our previous study, we used HLA class II genotyping of patients in another region-Hokkaido, in northern Japan. "
02/01/1996 - "Sarcoidosis is a granulomatous disease showing a significant increase in the HLA-DR5, -DR6, and -DR8 associated alleles in Japanese. "
04/01/1995 - "Susceptibility to the development of sarcoidosis has been demonstrated to be associated with HLA-DR5, -DR6, and -DR8 encoded by the DRB1 gene. "
03/01/1987 - "HLA-DR5 was found in 38 patients (52%) in group 1, compared with five (14%) in group 2 and 23 (14%) in group 3. In the one family studied, HLA-DR5 was present only in one member, who had sarcoidosis. "
01/01/1985 - "Hashimoto's thyroiditis was previously found to be associated with HLA-DR5 and Dw5. "
03/01/1981 - "We found HLA-DR5 to be present among 53% of 40 patients with goitrous autoimmune (Hashimoto's ) thyroiditis compared to 26% of 80 controls. "
05/01/1991 - "These results do not support a difference between goitrous and atrophic thyroiditis based on respective associations with HLA-DR5 and DR3, but confirm a recent study in which HLA-DR3 was associated with Hashimoto's thyroiditis. "
01/01/1987 - "Association between HLA-DR5 with different type of seizures was not found in this study."
08/01/1993 - "Of La Crosse encephalitis patients with acute-phase seizures, only 2 (7%) were positive for HLA-DR5, whereas 16 (37%) of nonseizure patients were positive for that antigen (P < .025). "
|5.||Chronic Kidney Failure (Chronic Renal Failure)
06/01/1994 - "The novel association of HLA-DR5 may reflect the fact that the MGN cases in this study all had ESRD.(ABSTRACT TRUNCATED AT 250 WORDS)"
06/01/1994 - "The results of this study indicate that HLA-DR3 and HLA-DR5 are positively associated with ESRD due to MGN in patients of both races and that HLA-DR7 is negatively associated with MGN in whites. "
|1.||HLA-DR3 Antigen (HLA DR3 Antigen)
|3.||HLA-DR7 Antigen (HLA DR7 Antigen)
|4.||HLA-DR4 Antigen (HLA DR4 Antigen)
|6.||HLA-DR1 Antigen (HLA DR1 Antigen)
|7.||HLA-DR2 Antigen (HLA DR2 Antigen)
|9.||Antineutrophil Cytoplasmic Antibodies (ANCA)
|2.||Transplantation (Transplant Recipients)